Is Avonex Safe During Pregnancy?
Avonex (interferon beta-1a) is not recommended during pregnancy due to limited safety data and potential risks. Animal studies show adverse effects on fetal development, including reduced viability and skeletal abnormalities at doses similar to human levels. Human data from registries like the Interferon-β Pregnancy Registry indicate no clear increase in major birth defects, but outcomes are tracked due to the lack of large controlled trials.[1]
FDA Pregnancy Category and Labeling
Avonex carries a Pregnancy Category C rating under the old FDA system, meaning risk cannot be ruled out—animal reproduction studies show adverse effects, but no adequate human studies exist, and potential benefits may warrant use in some cases. Updated prescribing information advises against use unless benefits outweigh risks, with women of childbearing potential advised to use effective contraception.[2]
What Happens in Real-World Use?
Small cohorts of exposed pregnancies report live birth rates around 75-80%, miscarriage rates of 10-15%, and preterm delivery in about 15%, roughly comparable to the general population. No definitive teratogenic signal has emerged, but monitoring is essential. Discontinuation is often recommended upon pregnancy confirmation.[1][3]
Breastfeeding Considerations
Limited data exist on Avonex in breast milk; levels are likely low due to its large molecule size. The manufacturer suggests caution, and decisions should weigh maternal needs against infant risks.[2]
Alternatives for MS During Pregnancy
For relapsing-remitting MS, options like glatiramer acetate have more reassuring pregnancy data. Some disease-modifying therapies (e.g., certain monoclonal antibodies) are avoided entirely. Management often shifts to symptomatic treatment or monitoring during pregnancy.[3]
[1]
Drugs.com - Avonex Pregnancy
[2]
Avonex Prescribing Information
[3]
MS Pregnancy Registry Data